PA has been reported in 57% of children receiving GH therapy [19] but in general, pubertal development in PWS is characterized by normal adrenarche, pubertal arrest, and hypogonadism due to variable combinations of a unique primary gonadal defect and hypothalamic dysfunction [20,21]. Here, GH1 is linked to Prader-Willi syndrome.